REG1A and colorectal carcinoma: To determine the precise mechanisms underpinning the REG1α-mediated MYC upregulation, CRC cells were subjected to various pathway inhibitors and we noticed that only XAV-939 (a specific inhibitor of Wnt/β-catenin signaling) resulted in the decrease of MYC expression.